Mirabegron for treating symptoms of overactive bladder

Overactive bladder - mirabegron: equality impact assessment - guidance review (PDF 167 KB)

Overactive bladder - mirabegron: final appraisal determination information

Overactive bladder - mirabegron: final appraisal determination document (PDF 425 KB)

Overactive bladder - mirabegron: evaluation report information

Overactive bladder - mirabegron: evaluation report (PDF 480 KB)

Overactive bladder - mirabegron: appraisal consultation

Overactive bladder - mirabegron: appraisal consultation document information

Overactive bladder - mirabegron: evaluation report

Overactive bladder - mirabegron: pre-meeting briefing (PDF 617 KB)

Overactive bladder - mirabegron: Evidence Review Group report (PDF 3.8 MB)

Overactive bladder - mirabegron: Evidence Review Group report - factual accuracy check (PDF 122 KB)

Overactive bladder - mirabegron: ERG erratum (PDF 201 KB)

Overactive bladder - mirabegron: Astellas Pharma (PDF 6.78 MB)

Overactive bladder - mirabegron: clarification

Overactive bladder - mirabegron: NICE clarification letter (PDF 166 KB)

Overactive bladder - mirabegron: manufacturer response to the NICE clarification letter (PDF 1 MB)

Overactive bladder - mirabegron: patient group, professional group and NHS organisation submission statements

Overactive bladder - mirabegron: British Association of Urological Surgeons (PDF 91 KB)

Overactive bladder - mirabegron: Royal College of Nursing (PDF 95 KB)

Overactive bladder - mirabegron: expert written personal statements

Overactive bladder - mirabegron: Rogers (PDF 78 KB)

Overactive bladder - mirabegron: Stuart (PDF 339 KB)

Overactive bladder - mirabegron: Venn (PDF 31 KB)

Overactive bladder - mirabegron: Williams (PDF 233 KB)

Overactive bladder - mirabegron: appendix B - final scope (PDF 49 KB)

Overactive bladder - mirabegron: appendix C - final matrix (PDF 52 KB)

Overactive bladder - mirabegron: appendix D - NICE s response to consultee and commentator comments on the draft scope and provisional matrix (PDF 249 KB)

Overactive bladder - mirabegron: equality impact assessment form (PDF 54 KB)

Overactive bladder - mirabegron: appendix B - draft scope for consultation (pre-referral) - January 2012 (PDF 56 KB)

Overactive bladder - mirabegron: appendix C - provisional matrix (pre-referral) - January 2012 (PDF 32 KB)